期刊文献+

Clinical features of forty patients with primary biliary cirrhosis 被引量:2

40例原发性胆汁性肝硬化的临床特征(英文)
原文传递
导出
摘要 OBJECTIVE: To study the clinical features of patients with primary biliary cirrhosis (PBC) in order to improve the doctors' awareness of the disease. METHODS: General status, clinical manifestations and laboratory findings of 40 patients with PBC were reviewed.Thirty-seven patients were females (37/40), and the mean age at diagnosis was 50.5 +/- 7.8 years. The time interval from initial symptoms or preliminary diagnosis to final diagnosis was 24.0 +/- 23.6 months. RESULTS: The most frequently reported symptoms were fatigue (67.5%, 27/40), jaundice (60%, 24/40) and pruritus (32.5%, 17/40). Eight patients (20%) had associated auto-immune diseases (Sjogren's syndrome and/or rheumatoid a(c)arthritis). Serum alkaline phosphatase (ALP) and gamma glutamyl transpeptidase (gamma-GT) levels were markedly elevated (520.3 +/- 382.3 IU/L and 648.6 +/- 529.1 IU/L, respectively) in all patients, while alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were mildly elevated (82.6 +/- 54.5 IU/L and 100.7 +/- 47.2 IU/L, respectively). Twenty-four patients (60%) had a total bilirubin level >/= 34.2 micromol/L. Thirty-five patients (87.5%) had elevated serum immunoglobin M,and 97.5% of patients (39/40 ) were anti-mitochondrial antibody (AMA)/AMA-M2 positive. CONCLUSION: Elevated serum ALP and gamma-GT levels, together with a positive AMA/AMA-M2, can help the diagnosis of PBC. Liver biopsy is useful to confirm the diagnosis and to differentiate histopathological stages. Objective To study the clinical features of patients with primary biliary cirrhosis (PBC) in order to improve the doctors’ awareness of the disease. Methods General status, clinical manifestations and laboratory findings of 40 patients with PBC were reviewed. Thirty-seven patients were females (37/40), and the mean age at diagnosis was 50.5±7.8 years. The time interval from initial symptoms or preliminary diagnosis to final diagnosis was 24.0±23.6 months. Results The most frequently reported symptoms were fatigue (67.5%, 27/40), jaundice (60%, 24/40) and pruritus (32.5%, 17/40). Eight patients (20%) had associated auto-immune diseases (Sjogren’s syndrome and/or rheumatoid arthritis). Serum alkaline phosphatase (ALP) and gamma glutamyl transpeptidase (γ-GT) levels were markedly elevated (520.3±382.3 IU/L and 648.6±529.1 IU/L, respectively) in all patients, while alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were mildly elevated (82.6±54.5 IU/L and 100.7±47.2 IU/L, respectively). Twenty-four patients (60%) had a total bilirubin level ≥34.2 μmol/L. Thirty-five patients (87.5%) had elevated serum immunoglobin M, and 97.5% of patients (39/40) were anti-mitochondrial antibody (AMA)/AMA-M2 positive. Conclusion Elevated serum ALP and γ-GT levels, together with a positive AMA/AMA-M2, can help the diagnosis of PBC. Liver biopsy is useful to confirm the diagnosis and to differentiate histopathological stages.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2002年第6期904-908,156,共5页 中华医学杂志(英文版)
关键词 ADULT Aged Biopsy Needle FEMALE Hepatitis B Chronic Humans Liver Liver Cirrhosis Biliary Male Middle Aged 临床特征 原发性胆汁性肝硬化 胆汁淤积 抗线粒体抗体
  • 相关文献

参考文献18

  • 1Metcalf J;Howel D;James O.Primary biliary cirrhosis: epidemiology helping the clinician[J],1996.
  • 2James OF;Bhopal R;Howel D.Primary biliary cir rho sis once rare,now common in the United Kingdom?[J],1999(2).
  • 3Heathcote EJ.Management of primary biliary cirrhosis[J],2000(31).
  • 4Lindor KD;Dickson ER.Primary biliary cirrhosis,1999.
  • 5Leuschner M;Dietrich CF;You T.Characterization of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment[J],2000.
  • 6Poupon RE;Ouguerran K;Chretien Y.Cholesterol-lowing effect of ursodeoxycholic acid in patients with primary biliary cirrhosis[J],1993.
  • 7Gylling H;Vuoristo M;Farkkila M.The metabolism of cholestanol in primary biliary cirrhosis[J],1996.
  • 8Miyakawa H;Tanaka A;Kikuchi K.Detection of antimito chondrial autoant ibodies in immunofluorescent AMA-negative patients with primary biliary cirrhos is using recombinant autoantigens[J],2001(2).
  • 9Lacerda MA;Ludwig J;Dickson ER.Antimitochondrial antibody-negative primary biliary cirrhosis[J],1995.
  • 10Tsianos EV;Hoofnagle JH;Fox PC.Sjogren's syndrome in patients with primary biliary cirrhosis[J],1990(11).

共引文献2

同被引文献10

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部